BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 9, 1999
View Archived Issues
CyDex and Allergan sign Captisol licensing agreement
Read More
Metabolic Modulators and Chugai sign drug discovery agreement
Read More
LeIF adjuvant enhances therapeutic efficacy of leishmaniasis vaccine in humans
Read More
LeukoSite: year-end 1998 highlights
Read More
DiagnoCure: Q1 1999 highlights
Read More
NeoPharm to collaborate with NCI on cytotoxic cancer ligand
Read More
Available for licensing from NIH: use of thymosin alpha1 for wound healing
Read More
Aronex initiates phase I/II trial of Atragen in bladder cancer
Read More
GVAX prostate cancer vaccine enters additional phase I/II trial
Read More
Select Therapeutics submits pre-IND in Canada for anticancer compound
Read More
U. Penn team synthesizes novel analogues of Ritalin for treatment of cocaine addiction
Read More
Versicor and Pharmacia & Upjohn join forces for development of new oxazolidinones
Read More
Phase III trial of Aliminase in ulcerative colitis initiated
Read More
Trega's analgesic effective in postoperative pain study
Read More
Novel anticonvulsants described by RCT
Read More
Neurokinin antagonists from Solvay particularly useful for GI disorders
Read More
Apoptosis-inducing peptide discovered at Morinaga Milk
Read More
Tularik presents novel compounds with dual antiproliferative and hypolipidemic effects
Read More
Peptidomimetic GH secretagogues synthesized under Japanese-U.S. collaboration
Read More
New class of potent, selective human glucagon receptor antagonists presented by Merck
Read More
Corvas reports design, synthesis and activity of selective peptidomimetic uPA inhibitors
Read More
RPR-CMV-423: a promising candidate for treatment of human CMV infection
Read More
Selective, orally active beta3-adrenoceptor agonists identified at Merck
Read More
Phase Ib trial of NBI-34060 successfully completed by Neurocrine Biosciences
Read More
Anti-CMV activity of BDCRB evaluated in newly designed preclinical model
Read More
Preclinical results indicate potential value of clevudine in chronic HBV infections
Read More
Didox outperforms hydroxyurea in murine AIDS model
Read More
Hughes Institute prepares novel NNRTIs useful as microbicidal spermicides
Read More